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Abstract
Growing experimental evidences suggest the existence of direct relationships between the surface 
chemistry of nanomaterials and their biological effects. Herein, we have employed computational 
approaches to design a set of biologically active Carbon Nanotubes (CNTs) with controlled protein 
binding and cytotoxicity. Quantitative Structure-Activity Relationships (QSAR) models were built 
and validated using a dataset of 83 surface-modified CNTs. A subset of a combinatorial virtual 
library of 240,000 ligands potentially attachable to CNTs was selected to include molecules that 
were within the chemical similarity threshold with respect to the modeling set compounds. QSAR 
models were then employed to virtually screen this subset and prioritize CNTs for chemical 
synthesis and biological evaluation. Ten putatively active and ten putatively inactive CNTs 
decorated with the ligands prioritized by virtual screening for either protein binding or cytotoxicity 
assays were synthesized and tested. We found that all 10 putatively inactive and 7 out of 10 
putatively active CNTs were confirmed in the protein binding assay, whereas all 10 putatively 
inactive and 6 out of 10 putatively active CNTs were confirmed in the cytotoxicity assay. This 
proof-of-concept study shows that computational models can be employed to guide the design of 
surface-modified nanomaterials with the desired biological and safety profiles.
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 Introduction
Nanotechnology is emerging as a multi-purpose platform in many industrial applications 
(Demirdjian, 2006; Jones, 2009; Luther, 2004) resulting in various marketed products (Sips, 
2009) based on manufactured nanoparticles (MNPs). An increasing amount of evidence 
(Baalousha & Lead, 2013) suggests that nanomaterials may cause detrimental effects in 
living organisms (Bai et al., 2010; Maynard et al., 2006; Murray et al., 2012; Nel et al., 
2006; Qu et al., 2009; Service, 2004; Zhang et al., 2014). As interactions between MNPs and 
biological systems are extremely complex (Nel et al., 2009), both manufacturers and 
regulators are in need for new methods to design MNPs with controlled and safe bioprofiles 
(Kumar et al., 2014; Sips, 2009). Experimental in vivo toxicological studies (usually LD50 
assessment, but also MNPs biodistribution, serum binding chemistry, or tissue 
histopathology after exposure to MNPs) are time- and resource-consuming, making it 
unrealistic to test all marketed consumer products incorporating MNPs (Savolainen et al., 
2010). Extrapolating in vitro measurements to in vivo outcomes (Monteiro-Riviere et al., 
2013) is even more challenging. Meanwhile, computer simulation approaches have been 
widely explored and exploited in chemical toxicology (e.g., Tox21 project (Austin, 2009)) 
especially for organic compounds (Arts et al., 2008; European Parliament, 2010; Hartung, 
2010) to quickly assess their potential safety concerns (e.g., carcinogenicity (Zhu et al., 
2008a), aquatic toxicity (Zhu et al., 2008b), liver toxicity (Fourches et al., 2010a; Rodgers et 
al., 2010), etc.) with reasonable accuracy. Similarly, it would be highly desirable to develop 
computer-based approaches to (i) predict the biological (including toxicological) effects of 
MNPs solely from their physical, geometrical, and chemical properties (Carbó-Dorca & 
Besalú, 2011), and (ii) guide experimental investigations by focusing costly toxicological 
studies on a small number of selected or rationally designed MNPs. The need to develop 
such approaches has been well articulated in recent scientific literature (Burello & Worth, 
2011; Kar et al., 2014; Luan et al., 2014; Puzyn et al., 2009; Singh & Gupta, 2014; Winkler 
et al., 2012).
In an attempt to address these challenges, our group has recently pioneered a QSAR 
modeling approach (Fourches et al., 2011, 2010c) to develop computational models capable 
of predicting biological activities of MNPs from their composition and structural properties 
only. In our previous studies, we showed that computational models could help forecasting 
various biological effects such as protein binding or cellular uptake for diverse sets of MNPs 
with a reasonable prediction accuracy evaluated by the means of external validation using 
MNPs that were not employed for model development. Similar retrospective studies have 
been reported by our colleagues (Gajewicz et al., 2014; Kar et al., 2014; Luan et al., 2014; 
Puzyn et al., 2011; Singh & Gupta, 2014; Toropova et al., 2014) for different sets of MNPs. 
However, so far there has not been any published report where molecular modeling was 
employed prospectively as part of an experimental and iterative design of MNPs with the 
desired biological activity.
Since MNPs have very large surface area, surface chemistry is thought to play a key role in 
controlling their biological activities (Mu et al., 2014). One of our research groups published 
a promising study (Zhou et al., 2008) showing the possibility of perturbing both 
biocompatibility and toxicity of MNPs that have been synthesized using a combinatorial 
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chemistry approach (Su & Yan, 2010). In order to discover biologically benign nanotubes 
without a priori knowledge of related targets or potential mechanisms, we have exposed the 
biological targets of interest to multi-walled carbon nanotubes (CNTs) with diverse surface 
modifiers and very different molecular and physicochemical properties obtained through 
combinatorial nanotube library synthesis (Yan, 2011; Q. Zhang et al., 2010). Then we 
demonstrated the existence of relationships between the surface chemistry of CNTs 
covalently decorated with small organic ligands and their biological profiles assessed by a 
panel of protein binding and cytotoxicity assays. Better understanding and accurate 
prediction of biological effects caused by CNTs are of critical importance for ensuring their 
safe use in various medical applications with a therapeutic potential (e.g., drug carriers) 
(Kaiser et al., 2009; Y. Zhang et al., 2010). To the best of our knowledge, there is no 
published report on the prospective use of any computational approach for designing and 
prioritizing novel CNTs with the desired bioactivity and safety profiles.
Herein, we have modeled the structure-activity relationships for a set of 83 CNTs tested in 
six different biological or toxicological in vitro assays (Zhou et al., 2008). Using 
cheminformatics methods to characterize and cluster CNTs using structural descriptors of 
their surface-modifying molecules, we have uncovered chemical features of the modifiers 
that correlate with a particular biological activity. These initial results confirmed the direct 
relationships between surface chemistry and CNT bioprofiles observed previously (Zhou et 
al., 2008). Furthermore, we have developed several QSAR models with external prediction 
power as high as 75% and 77% balanced accuracy for protein binding and acute toxicity 
endpoints, respectively. In combination with similarity search, these models were used to 
screen in silico a virtual library of 240,000 ligands considered as potentially attachable to the 
surface of a CNT. A series of hits were selected for experimental validation, and the results 
showed a good agreement between predicted and measured bioprofiles: all rationally 
prioritized, synthesized, and tested CNTs predicted as inactive were confirmed 
experimentally in both protein binding and cytotoxicity assays, whereas six out of ten 
rationally prioritized CNTs predicted as toxic were also confirmed as were seven out of ten 
surface-modified CNTs predicted as protein binders. Thus, statistical QSAR models were 
used to rationally prioritize and design a series of surface modified CNTs that were 
experimentally confirmed with the expected biological and toxicological properties.
 Materials and methods
 CNT dataset and assays
We considered a library of 83 multi-walled CNTs, each one being decorated with small 
organic molecules through combinatorial and chemical conjugation. The initial series of 
surface molecules used to decorate CNTs were selected to have the most diverse molecular 
and physicochemical properties, such as solubility, hydrophobicity, stereochemical, and 
topological properties on the basis of computation. They were chosen from 806 
combinatorial conjugations (31 amines and 26 acylators), for which molecular properties 
were calculated by Accord and Pipeline Pilot from Accelrys. The entire selection workflow 
was published previously (Zhou et al., 2008). In this work, we used 83 multiwalled carbon 
nanotubes with a controlled size distribution: diameter of 40±10 nm and length of 250±120 
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nm. Functional group modifications are made at a density of five modifications per 10 nm2 
on the basis of a loading of 0.4 mmol/g and a surface area of 500 m2/g (from experimental 
measurements). Then every CNT was biologically characterized using six short-term in vitro 
assays: protein binding to bovine serum albumin (BSA), carbonic anhydrase (CA), 
chymotrypsin (CT), and hemoglobin (HB), as well as acute toxicity and immune toxicity 
properties. Briefly, the binding of CNTs to proteins were studied by steady-state 
fluorescence spectroscopy (acquired on a Hitachi F-4500 spectrofluorometer). Fluorescence 
quenching indicates differential protein binding affinity profile for the two groups of 
designed CNTs. Carbonic anhydrase (50 µg/mL) was excited at 280 nm and emission 
spectra (300–400 nm) were recorded. Spectra were measured before and immediately after 
addition of CNT (15 µg/mL). Ratio of F0 (initial) to F (modified) at 340 nm was used to 
evaluate protein binding affinity: F0/F indicates the extent of protein fluorescence quenching 
by 15 µg/ml of CNT as a result of CNT binding to the protein; F0 is the protein fluorescence 
intensity before CNT binding and F is the fluorescence intensity after CNT binding. The 
higher F0/F value represents stronger protein binding. Acute toxicity of CNTs was 
investigated by WST-1 assays, and the survival percentages after exposure of macrophages 
to CNTs were recorded. The WST-1 assay is commonly used to evaluate cell proliferation 
and cytotoxicity. It was used to test cell viability by measuring cellular dehydrogenase 
activity in the mitochondrion. Cytotoxicity is also the consequence of CNTs’ binding with 
protein receptors on cell surface. For the whole set of 83 decorated CNTs, the average of cell 
survival variations was found to be as low as 3.6% at (200 µg/mL) and 3.8% at (50 µg/mL). 
For immune toxicity endpoint, the secretion of nitric oxide (NO) by macrophages was 
measured after the exposure to CNTs. More details about the protocols and other 
experimental details can be found in the supplementary materials and in (Zhou et al., 2008). 
The chemical structures and in vitro bioprofiles of the 83 CNTs are also available in the 
Supplementary Material.
 Chemical Descriptors
In our previous proof-of-concept study (Fourches et al., 2010c), we hypothesized that 
relative biological activity of surface-modified nanoparticles with the same core correlates 
with structural features of organic molecules attached to the surface. This approach allows 
the use of classical molecular descriptors for characterizing surface modifiers. Thus, each 
CNT has been represented by a single copy of its surface modifying organic molecules 
encoded as SMILES strings. Following the guidelines published by us recently (Fourches et 
al., 2010b), structural curation procedures were carried out to obtain standardized two-
dimensional representations of surface modifiers. The latter were then represented by 
molecular descriptors computed with Dragon (Mauri et al., 2006) and MOE (Vilar et al., 
2008) software including constitutional, functional group counts, atom-centered fragments, 
walk and path counts, information indices, topological and electrostatic indices. Descriptors 
with zero value or zero variance as well as one of each pair of highly inter-correlated 
descriptors (R2 ≥ 0.95) were removed leaving 180 (Dragon) and 158 (MOE) descriptors for 
further cheminformatics analysis. For clustering (Downs & Barnard, 2002; Liu et al., 2008; 
Monti et al., 2003) compounds by chemical similarity, we employed the Sequential 
Agglomerative Hierarchical Non-overlapping (SAHN, classical Johnson’s algorithm) 
method implemented in the ISIDA/Cluster program (Varnek et al., 2008). When using this 
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combination of descriptors and clustering algorithm, the clusters were very stable and 
ensured to contain compounds with structural similarity. To validate the clusters, we 
analyzed the content of each cluster by studying the structural variations of molecules and 
that stage enabled the discovery of clusters containing CNT surface modifiers having 
consistent experimental responses in the considered protein binding assays.
 QSAR Modeling
The QSAR modeling workflow can be divided into three major steps (Tropsha & Golbraikh, 
2007; Tropsha, 2010): (i) data preparation/analysis (selection of compounds and 
descriptors), (ii) model building, and (iii) model validation/selection. Here we followed a 5-
fold external cross-validation procedure: the full set of compounds with known experimental 
activity is randomly split into five modeling (80% of the full set) and external validation sets 
(remaining 20%). Models are built using the modeling set only and it is important to 
emphasize that the external set compounds are never taken into account to build and/or 
select models. Briefly, each modeling set is split into many training and test sets; then 
models are built using compounds of each training set and applied to test set compounds to 
assess their properties. The following statistical metrics were used to assess model accuracy:
(1)
(2)
(3)
(4)
Best models are identified and selected according to acceptable values of CCRtraining and 
CCRtest thresholds (≥0.7 in this study). Other statistical tests (e.g., Y-randomization) are 
applied to assess the overall robustness and predictivity of the selected models. Then, these 
models are applied to the external set compounds to predict their experimental properties. 
This procedure is repeated five times to ensure that every compound is present in exactly one 
external test set. External test sets are never used to derive, bias, or select the models, so that 
the entire procedure gives a fair estimation of the true predictivity of the models. Technical 
details concerning the machine-learning methods used in this study (k Nearest Neighbors – 
kNN (Zheng & Tropsha, 2000), Random Forest – RF (Breiman, 2001), and Support Vector 
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Machines (Cristianini & Shawe-Taylor, 2000) - SVM) and definitions of the model 
applicability domain were published elsewhere (Fourches et al., 2010a; Tropsha & 
Golbraikh, 2007; Zhu et al., 2008b). For SVM, the Radial Basis Function (RBF) kernel has 
been used for the training of SVM models. For each fold (at each fold corresponds a pair of 
modeling set 80% and an external validation set 20%), a different number of models is 
selected (with gamma and cost parameters taking values in different ranges) according to 
both training and internal test sets. Despite the fact that the activity is binary in classification 
QSAR modeling, quantitative relationships between descriptors and the binary bioactivity 
are computed and optimized to achiev the best prediction performances. Importantly, the 
most predictive models (and details about their kernel parameters) are freely available online 
on our Chembench webportal (http://chembench.mml.unc.edu/). SVM/Dragon models for 
CA binding and acute toxicity are given as examples in Supplementary Tables 1 and 2.
 Results
 Clustering of CNTs chemical surface modifiers
All 83 surface-decorated CNTs were clustered according to the similarity of the chemical 
structures of the modifiers characterized by Dragon molecular descriptors (see Methods 
section). Initially, we were particularly interested in identifying and analyzing clusters of 
CNTs associated to extreme bioprofiles (e.g., strong protein binders, highly toxic CNTs). 
Protein binding of nanomaterials has been recently shown to affect their cellular uptake 
(Monteiro-Riviere et al., 2013). Since bovin serum albumin (BSA) binding of CNTs 
correlated rather poorly with their binding to other proteins, we focused on identifying 
clusters of CNTs (Figure 1) with consistent binding characteristics towards carbonic 
anhydrase (CA), chymotrypsin (CT), and hemoglobin (HB). Two clusters of CNTs with 
strong or weak protein binding were identified:
1. a cluster with weak binders consisted of five CNTs with benzene chloride 
(or 4-chlorophenyl) as R1 subgroup. This observation was in agreement 
with the previous experimental finding that benzene chloride moiety is a 
key building block that leads to low protein binding affinity (Zhou et al., 
2008);
2. a cluster with strong binders was comprised of four CNTs with high 
protein binding activity across three assays. All these four CNTs included 
ethyl benzoate as R2 substituent. Among them, the CNT with the weakest 
protein binding contained a benzene chloride subgroup as R1 substituent.
Thus, the presence of benzene chloride on the CNT surface not only reduces the potential of 
CNTs to bind proteins, but also dominates the overall protein binding behavior of CNTs. 
Note that (i) the use of different molecular descriptors (e.g., fragment descriptors) would 
lead to different clusters, and (ii) these results reconfirm that CNTs with similar chemical 
surface modifiers elicit similar biological and toxicological responses
 QSAR modeling of CNT protein binding and toxicity
Since all 83 CNTs had the same core structure, it is reasonable to hypothesize that the 
variation of their behavior in biological systems would be related, at least for the most part, 
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to the structural modifications of the surface-attached organic ligands (as shown by the 
dramatic changes of biological properties highlighted in the previous section). Therefore, we 
approximated MNPs’ structures in the context of QSAR modeling by surface modifiers 
solely represented by their chemical descriptors, which enables a classical cheminformatics 
treatment of the system. This approach was successfully employed in our previous study 
(Fourches et al., 2011, 2010c). A similar approach was also used by (Puzyn et al., 2011), 
when properties of metal-oxide MNPs were approximated by quantum mechanical 
properties of the metal oxide molecules themselves. We aimed to establish quantitative links 
between computed physical, chemical, and structural properties of CNTs’ surface modifiers 
with experimentally measured biological or toxicological activities. Although the modeling 
was carried out for surface ligands, the experimentally measured biological activities relate 
to nanoconjugates (i.e., the whole decorated CNT), not the free ligands. The same assays 
done with free ligands would have given completely different outputs as confirmed by recent 
investigations. Indeed, in our previous research on CNT/Chymotrypsin binding and 
enzymatic inhibition (Zhang et al., 2009; Zhang et al., 2010), we found that four CNTs 
showed a typical feature for competitive inhibition. QSAR analysis found that a common 
building block dibutylamine group at the surface molecules of these CNTs helped to explain 
the structure-activity relationships of the CNT/ChT recognition. We further analyzed 
whether free dibutylamine molecules had any binding or inhibition of ChT. An interesting 
finding was that free dibutylamine molecules did not inhibit ChT’s enzymatic activity. 
Considering the large CNT/protein contact areas, this functional group, in combination with 
the nanotube and adjacent ligands, was likely crucial for targeting the catalytic site of ChT. 
In the present study, the QSAR models were trained, selected, and validated solely based on 
the bioactivities of the ligand-decorated nanomaterials, not free ligands. Nevertheless, we 
could use descriptors of surface modifying molecules only, not descriptors of entire 
nanoconjugates because QSAR models intrinsically correlate changes in chemical structure 
with changes in their bioactivities. Since the core structures are the same for all particles, we 
could ignore their (similar) contribution to bioactivity of different modified CNTs.
We have explored all six binary combinations of three machine learning techniques (kNN, 
RF and SVM) and two sets of chemical descriptors (calculated with Dragon or MOE) in an 
effort to develop QSAR models that would have the highest internal fitness and external 
predictive power (see Methods section for modeling workflow and computation details). 
Initial attempts to build QSAR models to compute the continuous response (e.g., actual 
percentage value of cell survival in cytotoxicity assay) failed due to poor-to-mediocre 
external predictivity irrespective of the combination of the modeling approach and the type 
of descriptors. This negative result can be explained by the small size of the dataset, the 
distribution of measured responses for protein binding and cytotoxicity assays as well as the 
experimental variability. Therefore, we switched to classification modeling by introducing 
an activity threshold such that the original set of CNTs was split into two balanced classes 
(labeled as 0 and 1, for low and high activity, respectively) with the intent to accurately 
predict the class membership of each CNT. QSAR models for each individual biological 
endpoint were constructed using our standard workflow (Tropsha, 2010). We were capable 
of developing statistically significant models for CA binding and acute cytotoxicity 
(measured by cellular metabolic activity in the WST-1 assay) (Supplementary Table 3). 
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Here, the expression “statistically significant” refers to the comparison of the prediction 
accuracy obtained by actual models with that obtained with models developed with 
randomized response variable (Y-randomization procedure); the latter models were 
characterized by very low internal accuracy estimated by cross-validation and no external 
predictivity.
In the case of CA binding, the activity values ranged from 0.53 to 5.29 at CNT concentration 
of 15 µg/ml (see Method for assay information). Based on the distribution of CA binding 
activities, we chose a separation threshold at 2.0 to split the dataset in two classes of CNTs 
with balanced distribution of actives and inactives. Thus, CNTs with the CA binding activity 
greater than 2.0 were assigned an activity value of 1 (CA binder) and those with binding 
affinity under 2.0 were assigned the activity value of 0 (CA non-binder). As a result, there 
were 44 CA binders and 39 CA non-binders. A standard 5-fold external cross-validation 
procedure was carried out and the results showed that the cumulative Correct Classification 
Rate (CCR) ranged from 63% to 75% (Supplementary Table 3). Only models with CCR no 
less than 70% were considered to have acceptable predictive power. Therefore, only kNN-
Dragon (75%) and RF-Dragon (73%) models were retained. Obviously, changing the 
separation threshold, for instance from 2.00 to 4.00, leads to an extremely unbalanced split 
of 8 CA strong binders and 75 CA non-binders for which no robust model can be built. Note 
that CNTs' protein binding measurements obtained in the CA, CT, and HB assays showed 
good pairwise correlation in the range of R2 = 0.58 – 0.65 (for instance, the correlation 
between CA and HB was found to be as high as R2 = 0.65), whereas BSA assay results were 
less correlated (R2 = 0.20 between BSA and CA). Therefore it is not surprising that 
modeling results obtained for CT and HB binding were similar to the ones obtained for CA.
Similarly to CA binding, the acute toxicity endpoint was modeled using the same workflow. 
The experimental survival percentage ranged from 2% to 68% at high CNT concentration of 
200 µg/ml. One could note that even as such high CNT concentration, some specific surface 
modifiers can still lead to weak CNT-induced toxicity. From the analysis of cytotoxicity 
values following a normal distribution, CNTs around the median cell survival range [37–
43%] were not included in the refined modeling set of 73 CNTs including 35 CNTs labeled 
as class 0 (“non-toxic”) and 38 CNTs labeled as class 1 (“toxic”). Frequently applied in 
QSAR modeling, this technique of discarding threshold was used to bias the selection of 
QSAR models for facilitating the discrimination between the most toxic CNTs and the less-
toxic CNTs. Calculated statistics showed that cumulative CCR ranged from 63% to 77%; 
kNN-Dragon, RF-Dragon and SVM-Dragon afforded the best external prediction 
performances in the range of CCR = 70–77%. To ensure the robustness of selected QSAR 
models, we employed standard Y-randomization test and found that no statistically 
significant models (i.e., with CCR >0.7) for datasets with randomized response variables 
were retrieved.
 Application of QSAR models for in silico screening of a virtual library of CNT surface 
modifiers
The most important objective of this study was the prioritization of CNTs for experimental 
testing and their confirmation to demonstrate how computational screening incorporating 
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similarity search and QSAR models can be used to facilitate the design of novel CNTs with 
the desired biological properties. To this end, we virtually screen an external compound 
collection consisting of 240,000 small molecules considered to be synthetically feasible and 
potentially attachable to the surface of CNTs. Figure 2 illustrates the workflow we 
implemented and followed.
 Construction of a virtual MWNT combinatorial library—We used the same 
scaffold as in the modeling set of CNTs with two sites of diversification. The amines and 
acylators were selected as modifying building blocks based on the following criteria: (i) 
diverse amines and acylators were selected to get the maximum surface diversity based on 
their estimated molecular properties such as hydrophobicity (MlogP), solubility, hydrogen-
bonding, and stereochemical properties calculated by Accord and Pipeline Pilot from 
Accelrys and (ii) both amines and acylators had to be commercially available. We finally 
selected 400 Acylators and 600 Amines to build a virtual library containing 240,000 
compounds being attachable to CNT surfaces.
 Similarity based filtering of surface modifiers—The similarity concept underlies 
many rational molecular design approaches; i.e., it is expected that similar chemical 
structures will have similar physical-chemical properties and thus cause similar biological 
responses. The first step in our virtual screening procedure aimed to identify among the 
240K compounds of the virtual library, those molecules that were not too dissimilar from the 
ones already tested as surface modifiers in our modeling set of 83 CNTs. The dissimilarity 
between compounds was computed using molecular descriptors (Dragon) and Euclidean 
metric between molecules represented as vectors in high-dimensional descriptor space. If the 
pairwise Euclidean distances between a compound from the library and any of the modeling 
set compounds exceeded a pre-defined distance threshold (here, a very strict z = 0.5 
threshold, see reference (Tropsha & Golbraikh, 2007)), this compound was excluded. 
Finally, only 462 compounds from the library of 240K molecules remained after the 
similarity-based filtering. It is important to note that setting up the distance threshold is 
directly related to the final number of compounds one wants to select in regard to the 
feasible number of compounds to be experimentally synthesized and tested. For instance, 
increasing our distance threshold to z =1 would have enabled the selection of several 
thousands of library compounds.
 Selection of Virtual Hits Using QSAR-based Consensus Predictions—The 
462 compounds retrieved from similarity search were evaluated using QSAR models 
developed for two endpoints, i.e., CA binding and acute toxicity. Models’ applicability 
domains (Tropsha & Golbraikh, 2007) were used to confirm that surface modifiers were 
similar enough from the modeling set compounds. Models predicted 352 ligand-decorated 
CNTs as binders, whereas only 110 compounds were predicted as non-binders. For the 
toxicity prediction, 189 out of 462 CNTs were predicted to be non-toxic, and the remaining 
273 compounds were predicted as potential toxicants. Final hit selections were made based 
on consensus scores (computed as the averaged predictions between individual QSAR 
models), and overall confidence coefficients (based on molecule similarity z to the modeling 
set and the standard deviation of predictions between the individual QSAR models). Finally, 
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ten predicted CA binders and ten predicted CA non-binders as well as ten predicted toxic 
CNTs and ten predicted non-toxic CNTs were recommended for experimental testing 
regarding their protein binding and cytotoxicity, respectively. Importantly, these compounds 
were selected based on (i) the highest prediction confidence from QSAR models, (ii) their 
structural diversity compared to the surface modifiers already present in the initial set of 83 
CNTs, and (iii) their overall synthetic feasibility.
 Experimental validation of the selected hits
CNTs decorated by computer-prioritized molecules were synthesized, purified, and 
characterized according to our established procedures (Zhou et al., 2008). Their chemical 
structures are given in Supplementary Table 4. These CNTs were experimentally tested in 
CA binding and cytotoxicity assays. For the cytotoxicity endpoint (Figure 3), 10 toxic and 
10 non-toxic hits as predicted by QSAR models were tested in THP-1 derived macrophage 
by measuring cellular metabolic activity (WST-1 method). Similarly, 10 QSAR-predicted 
CA binders and 10 non-binder CNTs (Table 1) were tested in a protein binding assay using 
fluorescence spectroscopy (Mu et al., 2008). Overall, for cytotoxicity endpoint, all 10 CNTs 
predicted to be non-toxic were confirmed as non-toxic, whereas 6 out of 10 CNTs predicted 
to be toxic were verified as being toxic (implying prediction accuracy of 80%, Figure 3). All 
QSAR-predicted non-toxic CNTs were characterized by higher cell survival percentages 
compared with those of predicted toxic CNTs. The statistical test (one sided student’s t-test, 
p<0.0001) showed that average cell viability of non-toxic hits was significantly higher than 
that of toxic hits. Given that the modeling set is biased towards cytotoxic CNTs, it is 
interesting to realize that our QSAR models were indeed able to identify surface modifiers 
leading to relatively low cytotoxicity such as II-7, II-8, and II-9 with cell survival 
percentages around 70%. Note the examination of replicate measurements for these 
compounds confirms the low cytotoxic CNTs with cell viability rates as high as 78.7% for 
II-6 and 82.4% for II-8 (Supplementary Figure 1). These results are very encouraging in the 
context of developing non-toxic surface-decorated CNTs. On the contrary, II-11 and II-16 
were found to be severe toxicants with cell survival rates as low as 28.9% and 24.4% 
confirming the predictions by our QSAR models. Nevertheless, despite their statistical 
significance, the results obtained for the compounds predicted to be cytotoxic were less clear 
due to experimental variability. For CA binding endpoint, all 10 CNTs predicted as binders 
were validated as binders, whereas 7 out of 10 CNTs predicted to be non-binders were 
confirmed as non-binders (overall prediction accuracy as high as 85%, Table 1).
 Discussion
This proof-of-concept study demonstrates the applicability of classical molecular modeling 
approaches that are well-established in the field of drug discovery to an unusual class of 
substances exemplified by decorated CNTs. Most importantly, we show that a virtual 
screening protocol can reasonably prioritize a small number of CNTs for experimental 
investigations calling for broader application of computational approaches to enable “safe-
by-design” development of MNP-based materials.
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 QSAR-prioritized descriptors of the surface modifiers
The preliminary analysis of individual descriptors involved in the best QSAR models was 
conducted. For CA binding models, several descriptors were found to take much higher 
values in binders: for instance, MATS2m (Moran autocorrelation of lag 2 weighted by mass) 
values were found to be twice as high in CA binders compared to CA non-binders; the 
H-051 descriptor (number of hydrogens attached to alpha carbons) was also more elevated in 
CA binders. Meanwhile, other descriptors such as nCl (number of chlorine groups) and 
several electrotopological indices (maxDN, GATS2m, and JGI2) were significantly more 
elevated in CA non-binders. One could note that all CNTs from the modeling set with 4-
chlorophenyl groups (directly encoded by nCl descriptor) in position R2 were found to be 
CA non-binders. For the WST model, several descriptors were more elevated in toxic 
modifiers such as nCp (number of terminal sp3 carbons) and BAC (Balaban centric index). 
Importantly, the selected descriptor nRNH2 (primary amines) highlights the fact that all 
primary amines were found to be toxic, whereas the descriptor nPyrrolidines (number of 
pyrrolidine substructure) helped revealing that 8 out of 10 CNTs incorporating a pyrrolidine 
group were found to be non-toxic. The aforementioned descriptors could potentially be 
refined as structural alerts in the context of a given class of surface modifiers. However, our 
models take into account the actual number of structural fragments (e.g., number of Cl, 
number of pyrrolidine) to forecast the bioactivity, not only the absence/presence as standard 
alerts would do.
 Structural diversity of newly-synthesized CNTs
Although the initial set of 83 ligands is certainly limited in terms of chemical diversity, the 
overall dataset of surface modified CNTs is not built using highly congeneric compounds 
only. Importantly, measured bioactivities for these CNTs spread over the whole range of 
protein binding (no binding for AMOO2AC005 to very strong binding for MWNT-Tyr-
Fmoc) and cytotoxicity (very low for AMOO6AC003 to very high for AMOO5AC006). 
This significant distribution of bioactivity is predicated on the underlying chemical diversity 
of tested substances.
The use of rather conservative similarity threshold for the virtual screening only kept a small 
fraction of compounds in the diverse 240K compound library that were relatively similar to 
the training set molecules. Nevertheless, hits identified by the screening protocol still 
showed some unique chemical features. Let’s consider the example of 4-
trifluoromethylphenyl group present at the R2 position in six out of 10 toxic CNTs: this 
group was not present in the modeling set, whereas its closest analog being the 3-
trifluoromethylphenyl group was indeed present in 10 CNTs from the modeling set but 
always in position R1 (never in R2). We can also cite the example of the 4-nitro-3-
(trifluoromethyl)phenyl group present in three CNTs selected by QSAR models, (II-11, 
II-12 and II-13); this group is not found in any of the modeling set modifiers. Also note that 
cyclopentyl and cycloheptyl groups were present in four non-toxic CNTs selected by the 
models but were not present in the modeling set structures at all.
Solely using potential structural alerts (e.g., presence of cyclohexyl group in R1) would not 
allow a reliable ranking of hits in the virtual screening library. Indeed, cyclohexyl group 
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(AM003 in R1) is present in 10 CNTs of the modeling set: 6 are CA-binders, 4 CA-
nonbinders, 6 toxic, 4 non-toxic. Phenyl group (AM004 in R1) is present in 10 CNTs of the 
modeling set: 4 CA-binders, 6 CA-nonbinders, 6 toxic, 4 non-toxic. Benzyl group (AM005 
in R1) is present in 10 CNTs of the modeling set: 5 CA-binders, 5 CA-nonbinders, 5 toxic, 5 
non-toxic. Therefore only the use of screening protocol involving similarity search and 
QSAR-based prioritization could both enable the accurate classification of CNTs and the 
rational design of novel substances with the desired bioactivity profiles. Moreover, the 
screening of 240,000 molecules is a task that is unlikely to be accomplished effectively 
manually. We plan to expand the chemical diversity in the future series of decorated CNTs.
 Limitations of this study
In this work, CNTs only differ by the types of small organic compounds that decorate their 
surface. Experiments showed that the biological properties of these decorated CNTs 
dramatically vary from one organic modifier to another. Given that their cores are the same, 
it is logical to expect that certain chemical features (encoded by molecular descriptors) of 
the surface modifiers do influence biological activities of decorated CNTs. Molecular 
descriptors were exclusively computed for modifiers to characterize their molecular 
connectivity, size, partial charges, bulkiness, that could contribute to CNTs bioactivity. 
QSAR models using these descriptor values were shown to achieve a reasonable predictive 
power justifying their utility to prioritize the modifiers to be use for the synthesis of novel 
CNTs.
We should underline again that the choice of activity classification thresholds greatly 
influences the modeling performances and especially the mispredictions of CNTs near the 
threshold borders (e.g., 2.0 for the CA binding assay). Choosing a different threshold would 
affect the balance between active and inactive compounds making it impossible to develop 
any model. In the case of CA, using a threshold of 2.0 (the activity ranging from 0.53 to 
5.29) discriminates 44 binders versus 39 non-binders. If the threshold is changed to 1.8, 49 
binders and 34 non-binders are defined. If the threshold is changed to 2.2, 40 binders and 43 
non-binders are defined. We do observe that the activity values follow a normal distribution 
around the threshold (no bimodal distribution here). Indeed, we could have moved the 
threshold numerous times and rebuild models to optimize the prediction performances and 
identify the best threshold; given the above analysis, relatively few compounds would have 
changed their class assignment for as long as we keep the dataset balanced and therefore the 
model statistics would stay the same (e.g., a threshold of 2.1 leads to identical QSAR 
models). Similarly, the threshold used for cytotoxicity is also critical since the modeling set 
is biased toward cytotoxic CNTs (only 6 CNTs from the modeling set are associated with a 
cellular survival rate higher than 60% at 200 µg/mL). However, given that we have built 
binary models using an ensemble QSAR approach where individual models make binary 
predictions (toxic or “1”, non-toxic or “0”), these individual predictions are averaged to 
output a predicted value between “0” and “1” so our choice of overall threshold is valid.
This study was strictly related to evaluating and predicting toxicity for surface modified 
CNTs tested in the reported in vitro assays. The issue of in vitro to in vivo extrapolation was 
obviously beyond the scope of this work. We shall also stress that due to study design, our 
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observations and conclusions are strictly limited to modified CNTs. Graphene oxides, 
polycyclic aromatic hydrocarbons and CNTs can theoretically be decorated with the same 
small molecules on their surface. Although the intensity and diversity of toxicity effects 
reported in the literature (cf. the excellent review by (Jastrzebska et al., 2012)) resonates 
with the ones reported for CNTs, there is no indication that graphene/PAHs decorated with 
the same surface modifiers would induce the same biological effects as those of CNTs. Our 
results do not suggest that our models could be applied to any other types of surface-
modified nanomaterials since their toxicity or any measured property is likely governed by 
different structural features.
It is also interesting to note that some other research groups (Shao et al., 2013; Singh & 
Gupta, 2014) recently attempted and succeeded to model 29 CNTs (subset of the 83 CNTs 
from this work) but used the indirect CNT rank (ranging from 1 to 83) as the modeling 
endpoint (not the actual, measured activity as done in this study).
 Limitations of the approach
The approach used in this study is not without important limitations due to the assumptions 
that are inherent to this technique of surface characterization. Indeed, QSAR modeling is not 
been used to fully analyze and understand the complexity of all nano-bio interactions (Nel et 
al., 2009) and features that are involved in defining the bioactivity of the CNTs. As 
illustrated by our results, we used this approach to explain the differences in reported 
bioactivity in terms of the differences in the structure of the surface modifiers. Our 
experimental results show that the collection of 83 CNTs is characterized by a quite 
significant diversity of biological responses that cannot be explained by minor variations in 
the size and other properties of the same CNT core common to all substances. Thus, we 
explain the variability of biological response by the variance in the structures of the surface 
modifiers and identify structural features and SAR trends that are responsible for this 
variability. Importantly, cytotoxicity is also the consequence of the binding of CNTs with 
protein receptors on cell surface. We should also underline that: (i) if the molecular 
descriptors were completely inadequate to characterize CNT surfaces, then the prediction 
power of the QSAR models built using these descriptors would be close to random and this 
is not the case (as confirmed by Y-randomization results); (ii) as of today, there is no other 
available approach capable of characterizing 80+ CNTs with computationally derived 
parameters and using them to build predictive models and prospectively guide the design of 
novel nanomaterials with the desired properties; (iii) our approach was validated by 
accurately predicting both active and inactive CNTs that were confirmed experimentally.
 Perspectives
The unfortunate truth is that records on biologically tested MNPs are extremely scarce. Our 
pioneering study of a dataset of 100+ surface-modified MNPs with the same metal core 
tested for their cancer cell uptake (Fourches et al., 2010c) has been repeated in the literature 
at least five times (e.g., (Chau and Yap, 2012; Ghorbanzadeh et al., 2012; Chandana Epa et 
al., 2012; Toropov et al., 2013)) with similar if not poorer statistical characteristics for the 
reported models. This unfortunate situation continues to severely limit the opportunities to 
develop and validate additional QSAR models; even a dataset of 80+ CNTs is relatively 
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small to try meaningful sensitivity and descriptor analyses given the need to set aside a 
significant fraction of compounds for external model validation. Additional obvious pitfalls 
possibly affecting model accuracy is, by necessity, a simplified representation of surface-
modified CNTs that does not take into account the location, density, and other structural 
aspects of these substances related to modifier-core interaction. We are also exploring 
additional approaches to improve model predictivity, e.g., by using layers of classification 
models (binary and multi-class) with different activity thresholds and testing other types of 
chemical descriptors. Nevertheless, similar to our previous studies (Fourches et al., 2010c), 
we have managed as a proof-of-concept to develop validated models and showed that with 
all the above limitations they could guide experimental synthesis. QSAR models could aid in 
the rational design of surface-modified MNPs and this study may encourage more 
experimental, large scale investigations in nanomaterial science, which will in return 
promote further development of the nascent modeling field for nanomaterials.
 Conclusions
This study presents the computer-aided rational design of nanomaterials, in which a 
complete development cycle comprising the initial chemical and biological data generation, 
QSAR model building, and QSAR-based virtual screening followed by computational hit 
identification and experimental validation, was realized. We have demonstrated that QSAR 
models built and selected following rigorous guidelines (Tropsha, 2010) can be used to (i) 
evaluate the activity profiles of surface-decorated nanomaterials, (ii) virtually screen large 
chemical libraries of MNP-attachable ligands, (iii) select and identify chemicals based on 
predicted bioprofiles, and overall (iv) help designing safer MNPs. The reasonable agreement 
between computer-selected hits and their experimentally assessed biological profiles 
validates both the rationale and the overall efficacy of our modeling methods and workflow. 
The results of this study suggest that QSAR models can be successfully employed for 
rational discovery of novel nanoparticles with the desired properties (i.e., reduced toxicity 
and low protein binding) and more generally, for the design of MNPs with controlled 
biological and safety profiles.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Clusters of CNTs; protein binders are shown in red and non-binders are in blue. (A) 
Dendrogram generated with non-supervised hierarchical clustering method; the heatmap 
represents the protein binding activities of the CNTs ordered according to the dendrogram. 
Red color stands for high activity while blue color for low activity. (B) The blue cluster 
represents five compounds incorporating common substructure (benzene chloride) 
highlighted in blue square. They behave similarly (low) activity in four protein binding 
assays. (C) The red cluster represents four compounds sharing a common substituent (ethyl 
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benzoate, highlighted in the red square) causing similar (strong) protein binding responses as 
measured in four different assays.
Fourches et al. Page 19
Nanotoxicology. Author manuscript; available in PMC 2017 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Workflow for virtual screening of 240 000 small molecules attachable to CNTs
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Figure 3. Cytotoxicity of novel CNTs prioritized for testing based on QSAR predictions
Cell viability of THP-1 macrophage cells in the presence of CNTs (200 µg/mL, 24h). THP-1 
macrophage cell microscopy images incubated (A) without CNT for 24 h, (B) with 200 
µg/mL II-8 CNT, and (C) with 200 µg/mL II-11 CNT. (D) Summary of experimental 
validation results for cytotoxicity of selected hits. CNTs are labeled as “0” (non-toxic) if 
their associated cell viability is greater than 50% and “1” (toxic) if their associated cell 
viability is smaller than 50%.
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